Michele A Valentin

Efficacy and safety of valsartan in children aged 1–5 years with hypertension, with or without chronic kidney disease: a randomized, double-blind study followed by open-label phase

A. Jankauskienė, D. Drożdż, A. Wasilewska, 2021, Current medical research and opinion.

Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension

R. Lou-Meda, B. Stiller, H. Yap, 2018, Pediatric Nephrology.